Novel Pyrazoline Derivatives as Therapeutic Candidate for Alzheimer’s Disease: An Integrated Network Pharmacology and 3D-QSAR Modelling
Alzheimer’s disease (AD) is a complex neurodegenerative condition marked by amyloid-β accumulation, tau pathology, and neuroinflammation, while current single-target therapies largely provide symptomatic relief without effectively halting disease progression. Therefore, the rational design and synthesis of novel small...